Lineage-restricted function of nuclear factor κB-inducing kinase (NIK) in transducing signals via CD40

Journal of Experimental Medicine

Volumn 191, Issue 2, 2000, Pages 381-385

  Garceau, Norman ^a   Kosaka, Yoko ^a   Masters, Sally ^a   Hambor, John ^b   Shinkura, Reiko ^c   Honjo, Tasuku ^c   Noelle, Randolph J ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b PFIZER INC   (United States)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Alymphoplasia mice; CD40 signaling; Dendritic cell; Nuclear factor B activation; Nuclear factor B inducing kinase

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHOTRANSFERASE;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELL LINEAGE; CELLULAR IMMUNITY; DENDRITIC CELL; HUMORAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD40; B-LYMPHOCYTES; CD40 LIGAND; CELL LINEAGE; CELLS, CULTURED; COS CELLS; DENDRITIC CELLS; DNA-BINDING PROTEINS; I-KAPPA B PROTEINS; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; NF-KAPPA B; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION;

EID: 0034677019     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.191.2.381     Document Type: Article

References (38)

1. Noelle, R.J. 1998. CD40 and its ligand in cell-mediated immunity. Agents Actions Suppl. 49:17-22.
2. Xu, J., T.M. Foy, J.D. Laman, E.A. Elliott, J.J. Dunn, T.J. Waldschmidt, J. Elsemore, R.J. Noelle, and R.A. Flavell. 1994. Mice deficient for the CD40 ligand. Immunity. 1:423-431.
3. Kawabe, T., T. Naka, K. Yoshida, T. Tanaka, H. Fujiwara, S. Suematsu, N. Yoshida, T. Kishimoto, and H. Kikutani. 1994. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity. 1:167-178.
4. Foy, T.M., A. Aruffo, J.A. Ledbetter, and R.J. Noelle. 1993. In vivo CD40-gp39 interactions are essential for thymus-dependent immunity. II. Prolonged in vivo suppression of primary and secondary humoral immune responses by an antibody targeted to the CD40 ligand, gp39. J. Exp. Med. 178: 1567-1575.
5. Caux, C., C. Massacrier, B. Vanbervliet, B. Dubois, C. van Kooten, I. Durand, and J. Banchercau. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1263-1272.
6. Mackey, M.F., R.J. Barth, Jr., and R.J. Noelle. 1998. The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J. Leukoc. Biol. 63:418-428.
7. Banchereau, J., B. Dubois, J. Fayette, N. Burdin, F. Briere, P. Miossec, M.C. Rissoan, C. van Kooten, and C. Caux. 1995. Functional CD40 antigen on B cells, dendritic cells and fibroblasts. Adv. Exp. Med. Biol. 378:79-83.
8. Berberich, I., G.L. Shu, and E.A. Clark. 1994. Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B. J. Immunol. 153:4357-4366.
9. Hu, H.M., K. O'Rourke, M.S. Boguski, and V.M. Dixit. 1994. A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 269:30069-30072.
10. Ishida, T.K., T. Tojo, T. Aoki, N. Kobayashi, T. Ohisho, T. Watanabe, T. Yamamoto, and J. Inoue. 1996. TRAF5, a novel tumor necrosis factor-receptor associated factor family protein, mediates CD40 signaling. Prof. Natl. Acad. Sci. USA, 93:9437-9441.
11. Ishida, T., S. Mizushima, S. Azuma, N. Kobayashi, T. Tojo, K. Suzuki, S. Aizawa, T. Watanabe, G. Mosialos, E. Kieff, et al. 1996. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J. Biol. Client. 271:28745-28748.
12. Regnier, C.H., G. Tomasetto, C. Moog-Lutz, M.P. Chenard, C. Wendling, P. Basset, and M.C. Rio. 1995. Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma. J. Biol. Chem. 270: 25715-25721.
13. Roche, M., S.C. Wong, W.J. Henzel, and D.V. Goeddel. 1994. A novel family ot putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell. 78:681-692.
14. Song, H.Y., C.H. Regnier, C.J. Kirschning, D.V. Goeddel, and M. Rothe 1997. Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-Jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proc. Natl. Acad. Sci. USA. 94:9792-9796.
15. Kuhne, M.R., M. Robbins, J.E. Hambor, M.F. Mackey, Y. Kosaka, T. Nishimura, J.P. Gigley, R.J. Noelle, and D.M. Calderhead. 1997. Assembly and regulation of the CD40 receptor complex in human B cells. J. Exp. Med. 186:337-342.
16. Rothe, M., V. Sarma, V.M. Dixit, and D.V. Goeddel. 1995. TRAF2-mediated activation of NF-kappaB by TNF receptor 2 and CD40. Science. 269:1424-1427.
17. DiDonato, J., F. Mercurio, C. Rosette, J. Wu-Li, H. Suyang, S. Ghosh, and M. Karin. 1996. Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 16:1295-1304.
18. Malinin, N.L., M.P. Boldin, A.V. Kovalenko, and D. Wallach. 1997. MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature. 385:540-544.
19. Lee, F.S., R.T. Peters, L.C. Dang, and T. Maniatis. 1998. MEKK1 activates both IkappaB kinase alpha and IkappaB kinase beta. Proc. Natl. Acad. Sci. USA. 95:9319-9324.
20. Lee, F.S., J. Hagler, Z.J. Chen, and T. Maniatis. 1997. Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway. Cell. 88:213-222.
21. Zandi, E,. and M. Karin. 1999. Bridging the gap: composition, regulation, and physiological function of the IkappaB kinase complex. Mol. Cell. Biol. 19:4547-4551.
22. May, M.J., and S. Ghosh. 1998. Signal transduction through NF-kappaB. Immunol. Today. 19:80-88.
23. Futterer, A., K. Mink, A. Luz, M.H. Kosco-Vilbois, and K. Pfeffer. 1998. The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity. 9:59-70.
24. De Togni, P., J. Goellner, N.H. Ruddle, P.R. Streeter, A. Fick, S. Mariathasan, S.C. Smith, R. Carlson, L.P. Shornick, J. Strauss-Schoenberger, et al. 1994. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science. 264:703-707.
25. Shinkura, R., K. Kitada, F. Matsuda, K. Tashiro, K. Ikuta, M. Suzuki, K. Kogishi, T. Serikawa, and T. Honjo. 1999. Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappaB-inducing kinase. Nat. Genet. 22: 74-77.
26. Roy, M., A. Aruffo, J.A. Ledbetter, P. Linsley, M. Kehry, and R.J. Noelle. 1995. Studies on the independence of gp39 and B7 expression and function during antigen-specific immune responses. Eur. J. Immunol. 25:596-603.
27. Buhlmann, J.E., M. Gonzalez, B. Ginther, A. Panoskaltsis-Mortari, B.R. Blazar, D.L. Greiner, A.A. Rossini, R. Flavell, and R.J. Noelle. 1999. Cutting edge: sustained expansion of CD8+ T cells requires CD154 expression by Th cells in acute graft versus host disease. J. Immunol. 162:4373-4376.
28. Aruffo, A., M. Farrington, D. Hollenbaugh, X. Li, A. Milatovich, S. Nonoyama, J. Bajorath, L.S. Grosmaire, R. Stenkamp, M. Neubauer, et al. 1993. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell. 72:291-300.
29. Maraskovsky, E., K. Brasel, M. Teepe, E.R. Roux, S.O. Lyman, K. Shortman, and H.J. McKenna. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184:1953-1962.
30. + T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J. Exp. Med. 186: 2057-2062.
31. Sakata, N., H.R. Patel, N. Terada, A. Aruffo, G.L. Johnson, and E.W. Gelfand. 1995. Selective activation of c-Jun kinase mitogen-activated protein kinase by CD40 on human B cells. J. Biol. Chem. 270:30823-30828.
32. Paris, M., F. Gaskin, J.T. Parsons, and S.M. Fu. 1994. CD40 signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase Lyn, Fyn, and Syk and the appearance of a 28-kD tyrosine phosphorylated protein. J. Exp. Med. 179:1923-1931.
33. Cella, M., D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin 12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:747-752.
34. Sallusto, F., B. Palermo, D. Lenig, M. Miettinen, S. Matikainen, I. Julkunen, R. Forster, R. Hurgstahler, M. Lipp, and A. Lanzavecchia. 1999. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur. J. Immunol. 29:1617-1625.
35. Lin, X., E.T. Cunningham, Jr., Y. Mu, R., Geleziunas, and W.C. Greene. 1999. The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-kappaB acting through the NF-kappaB-inducing kinase and IkappaB kinases. Immunity. 10:271-280.
36. Conley, M.E., M. Larche, V.R. Bonagura, A.R. Lawton III, R.H. Buckley, S.M. Fu, E. Coustan-Smith, H.G. Herrod, and D. Campana. 1994. Hyper IgM syndrome associated with defective CD40-mediated D cell activation. J. Clin. Invest. 94:1404-1409.
37. Durandy, A., C. Hivroz, F. Mazerolles, C. Schiff, F. Bernard, E. Jouanguy, P. Revy, J.P. DiSanto, J.F. Gauchat, J.Y. Donnefoy, et al. 1997. Abnormal CD40-mediated activation pathway in B lymphocytes from patients with hyper-IgM syndrome and normal CD40 ligand expression. J. Immunol. 158:2576-2584.
38. Revy, P., F. Geissmann, M. Debre, A. Fischer, and A. Durandy. 1998. Normal CD40-mediated activation of monocytes and dendritic cells from patients with hyper-IgM syndrome due to a CD40 pathway detect in B cells. Eur. J. Immunol. 28:3648-3654.